SBIR/STTR Research Award

Engineered Pan-Specific Reagents for N-Glycan Detection and Enrichment

Award identifier 22feb977ad663bb12052079b32133278372ceef649fffb6c18297fdc5fea91d9Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$2,018,187

Program and phase

SBIR · Phase II

Award year

2024

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LECTENZ BIO, INC.
Proposal award date
2024-09-15
Contract end date
2026-08-31
UEI
JTGCK219C6F4
Solicitation number
PA22-176
Topic code
100

Research abstract

PROJECT SUMMARY Glycans play crucial roles in nearly every aspect of biological processes, and their distinct properties make them appealing as disease biomarker targets. However, due to their highly branched and variably linked nature, glycans pose a challenge for detection, purification, and structural analysis. Although advanced analytical techniques and instrumentation have been developed that target glycans, there is still a great need for reagents with well-defined carbohydrate specificity and high affinity that can be used to independently interrogate or enrich carbohydrate samples prior to traditional analyses. Lectenz Bio has been engineering glycan-processing enzymes and glycan-binding proteins into high-affinity glycan-specific reagents with tunable properties. The Fbs1 component of the E3 ubiquitin ligase complex recognizes glycans as part of its biological role in ubiquitylation. It is therefore a promising protein for conversion into a binding reagent for asparagine-linked glycans (N-glycans), which we will achieve by employing computational modeling and directed evolution. Initial studies demonstrate that Fbs1 can be readily expressed in E. coli, and binds specifically to N-glycosylated peptides and proteins, and not to the corresponding non-glycosylated peptides and proteins. However, it does demonstrate a preference for certain N-glycan structures. A pan-specific N-glycan binding reagent would directly address the urgent need to tools to help detect glyco- biomarkers and could immediately benefit the field of glycomics/glycoproteomics by enabling sample pre- enrichment. After engineering and optimizing the production of recombinant Fbs1 and its engineered variants, Lectenz Bio will develop a suite of kits for its application in Western blotting, immunohistochemistry, ELISA, flow cytometry, and affinity chromatography.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

18 SBIR/STTR records share this UEI (2009–2025). Reported award amounts total $14,474,759. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.